SEC Comment Letter 0000000000-23-003972 to GE HealthCare Technologies Inc. (GEHC) (CIK 0001932393) (GEHC)

GE HealthCare Technologies Inc. (GEHC) (CIK 0001932393)
Date: April 20, 2023 · CIK: 0001932393 · Accession: 0000000000-23-003972

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

April 20, 2023

Author

Peter Arduini

Form

UPLOAD

Company

GE HealthCare Technologies Inc. (GEHC) (CIK 0001932393)

Letter

United States securities and exchange commission logo April 20, 2023 Peter Arduini Chief Executive Officer and Director GE HealthCare Technologies Inc. 500 W. Monroe Street Chicago, IL Re:GE HealthCare Technologies Inc. Draft Registration Statement on Form S-1 Submitted April 18, 2023 CIK No. 0001932393 Dear Peter Arduini: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Ansart at 202-551-4511 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Andrew Fabens

Show Raw Text

United States securities and exchange commission logo
April 20, 2023
Peter Arduini
Chief Executive Officer and Director
GE HealthCare Technologies Inc.
500 W. Monroe Street
Chicago, IL
60661
Re:GE HealthCare Technologies Inc.
Draft Registration Statement on Form S-1
Submitted April 18, 2023
CIK No. 0001932393
Dear Peter Arduini:
            This is to advise you that we do not intend to review your registration statement.
            We request that you publicly file your registration statement no later than 48 hours prior
to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
            Please contact Jessica Ansart at 202-551-4511 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Andrew Fabens

SecProbe.io